Business Wire

Boomi Named One of the 100 Best Workplaces for Innovators

Share

Fast Company includes Boomi in prestigious 2024 Best Workplaces for Innovators list, recognizing workplace culture that fosters innovation

Boomi™, the intelligent integration and automation leader, today announced that it has been named to Fast Company’s sixth annual Best Workplaces for Innovators list. Boomi received recognition for its workplace culture, which fosters innovation and promotes an open exchange of ideas, encouraging cross-functional collaboration and contributions from all levels to deliver exceptional value to customers.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240910948303/en/

Boomi Named One of the 100 Best Workplaces for Innovators (Graphic: Business Wire)

The 2024 Best Workplaces for Innovators list honors organizations and businesses that demonstrate an inspiring commitment to encourage and develop innovation at all levels. The 100 winners span a variety of industries, including entertainment, biotech, consumer packaged goods, marketing, education, and healthcare. Nominees were required to complete an application that addressed questions about projects, investment, companywide programs, and workplace culture. Fast Company editors evaluated every application and conducted additional research to generate a score for each company.

“We’re honored to be recognized by Fast Company as one of the Best Workplaces for Innovators,” said Arlen Shenkman, President at Boomi. “This recognition is a testament to Boomi’s long history of fostering a culture of innovation, where our core values celebrate being bold and taking calculated risks to deliver better outcomes for our customers, partners, and the communities in which we work. We take great pride in empowering our team members to contribute creatively, collaborate openly, and continually strive for innovation and excellence.”

As the pioneer of integration platform as a service (iPaaS), with one of the largest global customer bases among integration platform vendors, Boomi has a growing user community of more than 250,000 members and a worldwide network of approximately 800 partners. Boomi has been named to the 2024 Inc. 5000 list of the fastest-growing private companies in North America, and recognized by CRN as a Cloud 100 company and a 5-star Partner Program winner.

Over the past year, Boomi has taken a lead in AI innovation with the introduction of the Boomi AI Agent Framework and six inaugural Boomi AI Agents that enable customers to solve pressing integration and automation requirements by leveraging AI-driven capabilities. The company also recently launched Boomi API Control Plane — a centralized platform for discovering, managing, and governing APIs across an organization. As enterprise demand for digital connectivity, AI, integration, API management, and intelligent automation solutions grow, Boomi continues to deliver market-leading technology solutions that solve customers' complex challenges, streamline their operations, and drive innovation across their organizations.

“Innovation is a global priority that cuts across all industries, and this year’s list reflects that diversity,” says Brendan Vaughan, editor in chief of Fast Company. “The top ten features four companies headquartered outside of the U.S. and includes representatives from technology, advertising, finance, biotech, pharmaceuticals, ecommerce, and the nonprofit sectors.”

To view the complete list of the 100 Best Workplaces for Innovators, visit https://www.fastcompany.com/best-workplaces-for-innovators/list.

Fast Company’sBest Workplaces for Innovators issue (Fall 2024) is available online now, and the print issue will be on newsstands beginning September 17, 2024. Join the Best Workplaces for Innovators conversation using #FCBestWorkplaces.

Additional Resources

About Fast Company

Fast Company is the only media brand fully dedicated to the vital intersection of business, innovation, and design, engaging the most influential leaders, companies, and thinkers on the future of business. Headquartered in New York City, Fast Company is published by Mansueto Ventures LLC, along with our sister publication Inc., and can be found online at www.fastcompany.com.

About Boomi

Boomi, the intelligent integration and automation leader, helps organizations around the world automate and streamline critical processes to achieve business outcomes faster. Harnessing advanced AI capabilities, the Boomi Enterprise Platform seamlessly connects systems and manages data flows with API management, integration, data management, and AI orchestration in one comprehensive solution. With a customer base exceeding 20,000 companies globally and a rapidly expanding network of 800+ partners, Boomi is revolutionizing the way enterprises of all sizes achieve business agility and operational excellence. Discover more at boomi.com.

© 2024 Boomi, LP. Boomi, the ‘B’ logo, and Boomiverse are trademarks of Boomi, LP or its subsidiaries or affiliates. All rights reserved. Other names or marks may be the trademarks of their respective owners.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240910948303/en/

Contacts

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

4Moving Biotech Enrolls First Patient in Phase 2a Trial of 4P004, a Potential First-in-Class GLP-1 Therapy for Knee Osteoarthritis16.7.2025 07:00:00 CEST | Press release

- First patient enrolled in INFLAM MOTION, a global randomized Phase 2a trial including 129 knee osteoarthritis patients - 4P004 to be evaluated over 3 months for dual efficacy: symptom relief and synovial health improvement via contrast-enhanced MRI - Topline results expected in the second half of 2026 4Moving Biotech (4MB), a spin-off of 4P-Pharma dedicated to developing first-in-class treatments that modify the natural course of knee osteoarthritis (OA), today announced that the first patient has been enrolled in Phase 2a clinical trial, INFLAM MOTION. The study will evaluate 4P004, an intra-articular GLP-1 analog, as a potential first-in-class therapeutic candidate for knee osteoarthritis. INFLAM MOTION is a multicenter, randomized, double-blind, placebo-controlled Phase 2a trial planned to be conducted across Europe, the United States, and Canada. A total of 129 patients worldwide diagnosed with knee OA will be enrolled to evaluate, for the first time in humans, the efficacy of 4P

Belkin Achieves Qi2.2 Certification for Its Upcoming Products, Unlocking the Future of 25W Wireless Charging15.7.2025 19:06:00 CEST | Press release

With Qi2.2 certification, Belkin reinforces its commitment to quality, safety, and performance for the next generation of wireless charging Belkin, a leading consumer electronics brand for over 40 years, today announced it has received official Qi2.2 certification from the Wireless Power Consortium (WPC) for its upcoming products. As one of the first accessory brands to deliver Qi2.2-certified devices, Belkin is helping bring the next generation of wireless charging to market – enabling faster wireless charging speeds, broader compatibility, and improved performance for consumers. Belkin’s close partnership with the WPC since 2015 has been instrumental in bringing these advancements to consumers. As an early adopter and long-time contributor to WPC standards, Belkin was selected as one of a small group of trusted manufacturers to test and certify Qi2.2 products ahead of the broader industry rollout. All Belkin products undergo rigorous safety, quality, and performance testing. The comp

Cessna Grand Caravan EX to Feature New Executive Interior Options, Expanding Opportunities for Elevated Missions15.7.2025 18:05:00 CEST | Press release

The legendary Cessna Grand Caravan EX will now feature three new executive interior schemes for customers to select when designing their aircraft cabin. The Lunar, Obsidian and Saddle Sport interiors join the existing Canyon and Savanna schemes, providing a broader range of standard choices. The new interior options are available to customers starting this month and allow them to further tailor the interior of their aircraft based on their personal preference or mission. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250715021096/en/ Cessna Grand Caravan EX to feature new executive interior options, expanding opportunities for elevated missions (Photo Credit: Textron Aviation) The Cessna Grand Caravan EX is designed and manufactured by Textron Aviation Inc., a Textron Inc. (NYSE:TXT) company. Premium versions of each of the new interiors are also available, featuring quilted seat stitching and plush carpet, providing an elev

7 Million Tokens Sells Out in less than One Hour—$MBG Token Pre-Sale Shatters Expectations15.7.2025 17:27:00 CEST | Press release

MultiBank Group, the world’s largest and most regulated financial derivatives institution, has set a new benchmark in digital asset launches. The Group’s $MBG Token Pre-Sale sold out in less than one hour with all 7 million tokens fully subscribed across MultiBank.io and Uniswap. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250715055611/en/ The Group’s $MBG Token Pre-Sale sold out in less than one hour with all 7 million tokens fully subscribed across MultiBank.io and Uniswap. Commenting on the success of the Pre-Sale, Naser Taher, Founder and Chairman of MultiBank Group, said: “The sell-out of our initial $MBG Token offering in less than one hour is a decisive validation of our vision. In a market saturated with speculation, the response we received confirms that institutional-grade transparency, regulatory integrity, and asset-backed value are what investors are now demanding. $MBG is here for the long term, reflecting t

First Patient Enrolled in National Cancer Institute’s Vanguard Study Evaluating Guardant Health’s Shield Multi-Cancer Detection Test15.7.2025 17:01:00 CEST | Press release

Study addressing feasibility of using multi-cancer detection tests in future trials aims to enroll up to 24,000 participantsShield MCD reviewed by FDA as part of NCI’s investigational device exemption (IDE) Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that patient enrollment has begun in the National Cancer Institute (NCI)’s Vanguard Study to evaluate emerging multi-cancer detection (MCD) technology. Guardant’s Shield™ MCD test was selected for use in the four-year study, which aims to enroll up to 24,000 patients and evaluate the use of MCD tests—blood tests that can screen for several types of cancer simultaneously—in future randomized controlled trials. Guardant’s Shield MCD test was chosen for the study based on the overall performance of its Shield platform in detecting 10 cancer types, including lung, breast, colorectal, prostate, bladder, ovarian, pancreatic, esophageal, liver and gastric. The data were presented at the 2025 American

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye